santŽ ventures/headshots/casey

Casey Cunningham, MD Chief Scientific Officer

Casey Cunningham, MD is the Chief Scientific Officer of Santé Ventures. Dr. Cunningham received his fellowship training in oncology and hematology at Harvard Medical School, where he subsequently served on the faculty.  He was also one of the founding members of the Division of Experimental Medicine at the Brigham & Women’s Hospital in Boston, where he established a basic research laboratory in Cell and Molecular Biology.

He has over 70 publications in peer-reviewed journals and many abstracts and meeting presentations. Casey received his medical degree from the University of Texas Southwestern Medical School with a residency in Internal Medicine at the Medical College of Wisconsin. Casey returned to Texas in 1999 as the Associate Director of the Mary Crowley Cancer Research Center in Dallas, a position he held until 2007. He joined Santé Ventures shortly after its founding. He has served in operating roles in a number of portfolio companies and is currently on the Boards of Terapio Corp., Molecular Templates, Lyric Pharmaceuticals, Mirna Therapeutics and AbVitro.

News
April 30, 2015 Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology microRNA Pipeline
Read More
April 14, 2015 IBM Acquires Explorys to Accelerate Cognitive Insights for Health and Wellness
Read More